C WorldWide Group’s Krystal Biotech KRYS Stock Holding History

C WorldWide Group’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.5M	Sell	57,809 -10,000	-15%	-$2.99M	0.52%	31
2026 Q1	$17.5M	Sell	67,809 -18,000	-21%	-$4.79M	0.38%	35
2025 Q4	$21.2M	Hold	85,809	–	–	0.37%	37
2025 Q3	$15.1M	Hold	85,809	–	–	0.23%	48
2025 Q2	$11.8M	Hold	85,809	–	–	0.16%	57
2025 Q1	$15.5M	Sell	85,809 -20,000	-19%	-$3.36M	0.19%	44
2024 Q4	$16.6M	Sell	105,809 -30,000	-22%	-$5.32M	0.2%	43
2024 Q3	$24.7M	Hold	135,809	–	–	0.26%	49
2024 Q2	$24.9M	Hold	135,809	–	–	0.27%	48
2024 Q1	$24.2M	Sell	135,809 -50,000	-27%	-$6.95M	0.28%	48
2023 Q4	$23.1M	Hold	185,809	–	–	0.31%	34
2023 Q3	$21.6M	Hold	185,809	–	–	0.29%	31
2023 Q2	$21.8M	Sell	185,809 -40,000	-18%	-$4.08M	0.28%	32
2023 Q1	$18.1M	Hold	225,809	–	–	0.25%	40
2022 Q4	$17.9M	Hold	225,809	–	–	0.24%	35
2022 Q3	$15.7M	Hold	225,809	–	–	0.22%	36
2022 Q2	$14.8M	Hold	225,809	–	–	0.19%	35
2022 Q1	$15M	Buy	225,809 +40,000	+22%	+$2.5M	0.16%	39
2021 Q4	$13M	Hold	185,809	–	–	0.12%	43
2021 Q3	$9.7M	Hold	185,809	–	–	0.1%	47
2021 Q2	$12.6M	Hold	185,809	–	–	0.13%	45
2021 Q1	$14.3M	Hold	185,809	–	–	0.14%	50
2020 Q4	$11.1M	Hold	185,809	–	–	0.11%	52
2020 Q3	$8M	Buy	185,809 +50,000	+37%	+$2.17M	0.09%	54
2020 Q2	$5.63M	Hold	135,809	–	–	0.07%	58
2020 Q1	$5.87M	Buy	+135,809	New	+$7.1M	0.08%	53

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

C WorldWide Group's KRYS Position: Q2 2026 in Review

C WorldWide Group reduced its Krystal Biotech (KRYS) stake by 15% in Q2 2026, selling an estimated $2.99M and leaving 57,809 shares worth $21.5M. The position accounts for 0.52% of the portfolio, ranked #31.

C WorldWide Group first reported a position in KRYS in Q1 2020 and has held it in 26 quarters since. The position peaked at $24.9M in Q2 2024. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

C WorldWide Group held 57,809 shares of Krystal Biotech worth $21.5M as of Q2 2026.
C WorldWide Group sold 10,000 Krystal Biotech shares in Q2 2026, an estimated $2.99M.
Krystal Biotech made up 0.52% of C WorldWide Group's portfolio in Q2 2026, its #31 holding.
C WorldWide Group first reported a position in Krystal Biotech in Q1 2020 and has held it in 26 quarters since.
C WorldWide Group's Krystal Biotech position peaked at $24.9M in Q2 2024.
423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.